By precisely tuning the density and spatial arrangement of PSMA ligands, researchers have developed highly efficient PSMA-targeted PLGA nanoparticles that significantly improve cellular uptake in prostate cancer cells [251]. The gene discussed is FOLH1; the disease is prostate carcinoma.